The New York Times Company will have Jacqueline Welch step down as executive vice president and chief human resources officer on January 1, 2027. The transition matters to investors because Welch may receive severance benefits and payments tied to long-term performance awards, subject to release and restrictive-covenant conditions.
Key Highlights
- Severance eligibility depends on a general release of claims and compliance with applicable restrictive covenants.
- Welch qualifies for retirement treatment under long-term awards issued through the 2020 Incentive Compensation Plan.
- Jacqueline Welch will leave her roles as executive vice president and chief human resources officer on January 1, 2027.
- The transition includes severance eligibility and payments connected with long-term performance awards.
NEW YORK TIMES CO (NYSE: NYT) will undergo a senior human-resources Leadership change on January 1, 2027, when Jacqueline Welch leaves her roles as executive vice president and chief human resources officer. The transition also involves severance eligibility and payments connected with long-term performance awards. Those awards entitle her to receive payments.
Jacqueline Welch currently holds both the executive vice president and chief human resources officer positions. The stated financial consequences of the transition are severance eligibility and award payments, with the former subject to release and covenant requirements.
FAQs
Q: When will Jacqueline Welch leave The New York Times Company?
A: Jacqueline Welch will step down as executive vice president and chief human resources officer on January 1, 2027. The departure is part of a leadership change.
Q: What benefits may Jacqueline Welch receive after leaving NYT?
A: After leaving NYT, Jacqueline Welch is eligible for severance, subject to release and covenant requirements. She is also entitled to payments under long-term performance awards.
Q: What conditions apply to Jacqueline Welch’s severance?
A: Severance eligibility requires Welch to execute a general release of claims benefiting the company. She must also comply with applicable restrictive covenants.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.